May 2016: For the second consecutive year, Mundipharma has won the Award for Medium Ethical Suppliers with a focus on achieving excellence in Engaging with Symbion in all aspects of the business. The Award was received on 18 May in Melbourne in front of 200 guests...
Acquires licensing rights to formulated hydration product for pregnant and breastfeeding women Sydney, Australia, 17 May 2016: Mundipharma Pty Limited (Mundipharma) today announced an exclusive licensing agreement for hydration product aquamamma® in Australia and New Zealand. In the last couple of years, Obstetrician Dr Rob Buist became...
Anti-emetic products covered under the sublicense agreement include ALOXI (palonosetron hydrochloride) and AKYNZEO (netupitant/palonosetron) Melbourne, Australia, 7 March 2016: Specialized Therapeutics Pty Ltd and Mundipharma Pty Limited today announce a sublicense agreement enabling Mundipharma to assume all commercialisation responsibilities for the anti-emetic products ALOXI® (palonosetron hydrochloride)...
Nominations are now open for an educational grant to be awarded to an Australian pharmacist who has made an outstanding contribution to the Quality Use of Medicines through clinical care of consumers with persistent pain. Australia’s peak organisation for pharmacists, the Pharmaceutical Society of Australia (PSA)...
Sydney, 4th February, 2016: MPL staff headed to the Sydney Cricket Ground to support the Pain Research Management Institute and raise awareness against chronic pain. The day started with a cricket Marathon where MPL employees were privileged to play a game of cricket on the Sydney...
Jane Orr is Managing Director of Mundipharma Australia, but she is also a pharmacist, which gives her a unique perspective on community pharmacy. Although Mundipharma has traditionally had a strong prescription-medicines portfolio, it has recently diversified its business by investing in consumer health. The company...
Singapore, 3rd December, 2015: Mundipharma Ophthalmology Products Limited today announced an agreement with MSD, known as Merck in the United States and Canada, to acquire MSD’s ophthalmology portfolio for the treatment of increased ocular pressure caused by open angle glaucoma or ocular hypertension, in Australia,...
Mundipharma has once again received an industry award for its supply of prescription medicines. Last night in Melbourne, Mundipharma was recognised when winning the Sigma “Specialised Ethical Supplier of the Year” Award. Other Nominees included Amgen and Novo Nordisk. Robert Ingui, Finance and Operations director at Mundipharma...
Mundipharma ran its 100th Pain Management Master Classes in November 2015, with the program servicing over 4,500 healthcare practitioners all around Australia since it began. The Pain Management Master Classes were launched in 2009 as part of the CARE by mundipharma® offering (Clinical Academic Resources &...